Insider Transactions in Q3 2024 at Silk Road Medical Inc (SILK)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 17
2024
|
Donald Zurbay |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,610
-100.0%
|
-
|
|
Sep 17
2024
|
Elizabeth H Weatherman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
155,004
-100.0%
|
-
|
|
Sep 17
2024
|
Jack W Lasersohn |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,735
-100.0%
|
-
|
|
Sep 17
2024
|
Tony M. Chou |
SELL
Sale (or disposition) back to the issuer
|
Direct |
85,251
-100.0%
|
-
|
|
Sep 17
2024
|
Tanisha Carino |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,396
-100.0%
|
-
|
|
Sep 17
2024
|
Kevin J. Ballinger |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,666
-100.0%
|
-
|
|
Sep 17
2024
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
70
-100.0%
|
-
|
|
Sep 17
2024
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Sale (or disposition) back to the issuer
|
Direct |
231,961
-100.0%
|
-
|
|
Sep 17
2024
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+50.0%
|
-
|
|
Sep 17
2024
|
Rick D Anderson |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,966
-100.0%
|
-
|
|
Sep 17
2024
|
Marie L. Jones VP, Finance and CAO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
79,266
-100.0%
|
-
|
|
Sep 17
2024
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
191,988
-100.0%
|
-
|
|
Sep 17
2024
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
29,062
+50.0%
|
-
|
|
Sep 17
2024
|
Andrew S. Davis Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
332,295
-100.0%
|
-
|
|
Sep 17
2024
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,218
+50.0%
|
-
|
|
Sep 17
2024
|
Lucas W. Buchanan COO & CFO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
13,518
-100.0%
|
-
|
|
Sep 17
2024
|
Lucas W. Buchanan COO & CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
554,171
-100.0%
|
-
|
|
Sep 17
2024
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
50,876
+50.0%
|
-
|
|
Sep 17
2024
|
Chas Mc Khann Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,021,438
-100.0%
|
-
|
|
Sep 17
2024
|
Chas Mc Khann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,299,042
+50.0%
|
-
|
|
Aug 19
2024
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
SELL
Open market or private sale
|
Direct |
2,268
-1.37%
|
$61,236
$27.1 P/Share
|
|
Jul 03
2024
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
66
-0.02%
|
$1,782
$27.0 P/Share
|